| A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation P Sooriakumaran, J Karnes, C Stief, B Copsey, F Montorsi, P Hammerer, ... European urology 69 (5), 788-794, 2016 | 187 | 2016 |
| A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European … M Randazzo, A Müller, S Carlsson, D Eberli, A Huber, R Grobholz, ... BJU international 117 (4), 576-583, 2016 | 86 | 2016 |
| Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction ZI Attia, DM Harmon, J Dugan, L Manka, F Lopez-Jimenez, A Lerman, ... Nature medicine 28 (12), 2497-2503, 2022 | 58 | 2022 |
| A “PSA pyramid” for men with initial prostate-specific antigen≤ 3 ng/ml: a plea for individualized prostate cancer screening M Randazzo, J Beatrice, A Huber, R Grobholz, L Manka, FK Chun, ... European urology 68 (4), 591-597, 2015 | 45 | 2015 |
| Only size matters in stone patients: computed tomography controlled stone-free rates after mini-percutaneous nephrolithotomy D Kokov, L Manka, A Beck, A Winter, H Gerullis, PI Karakiewicz, ... Urologia internationalis 103 (2), 166-171, 2019 | 37 | 2019 |
| Limitations of elastography based prostate biopsy J Schiffmann, M Grindei, Z Tian, DJ Yassin, T Steinwender, ... Journal of Urology 195 (6), 1731-1736, 2016 | 33 | 2016 |
| Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau) M Randazzo, J Beatrice, A Huber, R Grobholz, L Manka, SF Wyler, ... World journal of urology 33, 1189-1196, 2015 | 29 | 2015 |
| Is further screening of men with baseline PSA < 1 ng ml−1 worthwhile? The discussion continues—Results of the Swiss ERSPC (Aarau) M Randazzo, J Beatrice, A Huber, R Grobholz, L Manka, FK Chun, ... International journal of cancer 137 (3), 553-559, 2015 | 26 | 2015 |
| Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients J Schiffmann, PI Karakiewicz, M Rink, L Manka, G Salomon, D Tilki, ... World journal of urology 36, 1067-1072, 2018 | 24 | 2018 |
| Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer J Schiffmann, L Manka, K Boehm, SR Leyh-Bannurah, PI Karakiewicz, ... World journal of urology 33, 1993-1999, 2015 | 24 | 2015 |
| 68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy J Kopp, D Kopp, E Bernhardt, L Manka, A Beck, H Gerullis, P Karakiewicz, ... World journal of urology 38, 3085-3090, 2020 | 22 | 2020 |
| PROPOSe: a real-life prospective study of proclarix, a novel blood-based test to support challenging biopsy decision-making in prostate cancer T Steuber, I Heidegger, M Kafka, MA Roeder, F Chun, F Preisser, ... European urology oncology 5 (3), 321-327, 2022 | 19 | 2022 |
| Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate—a comparison of patients with lower urinary tract symptoms and urinary retention P Trotsenko, C Wetterauer, P Grimsehl, T Möltgen, S Meierhans, L Manka, ... Lasers in medical science 36, 1397-1402, 2021 | 9 | 2021 |
| Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau) LW Prause, L Manka, C Millan, E Lang, SF Wyler, R Grobholz, ... World journal of urology 38, 2485-2491, 2020 | 8 | 2020 |
| 68Ga-prostate-specific membrane antigen positron emission tomography-computed tomography-based primary staging and histological correlation after extended pelvic lymph node … D Kopp, J Kopp, E Bernhardt, L Manka, A Beck, H Gerullis, PI Karakiewicz, ... Urologia Internationalis 106 (1), 56-62, 2022 | 7 | 2022 |
| Adherence to the EAU guideline recommendations for local tumor treatment in penile cancer: results of the European PROspective Penile Cancer Study Group Survey (E-PROPS) M Pallauf, MC Hempel, MC Hupe, M May, M Haccius, D Weckermann, ... Advances in therapy 37, 4969-4980, 2020 | 7 | 2020 |
| True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts J Schiffmann, G Mehring, P Tennstedt, L Manka, K Boehm, ... World journal of urology 34, 495-500, 2016 | 7 | 2016 |
| Prostate cancer screening: and yet it moves! M Kwiatkowski, M Randazzo, L Kluth, L Manka, A Huber, F Recker Asian journal of andrology 17 (3), 437-438, 2015 | 6 | 2015 |
| A positive family history as risk factor for prostate cancer in a population-based study with organized PSA-screening: Results of the Swiss ERSPC (Aarau) M Randazzo, A Müller, S Carlsson, D Eberli, A Huber, R Grobholz, ... BJU international 117 (4), 576, 2016 | 5 | 2016 |
| Effect of testosterone treatment in hypogonadal men on prostate cancer risk: Results of a prospective comparative study—8 years follow-up analysis to age-matched controls. DJ Yassin, L Manka, A Yassin, P Hammerer Journal of Clinical Oncology 32 (15_suppl), e16051-e16051, 2014 | 5 | 2014 |
